|
ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs.
We apply new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identify proprietary and related molecules for better patient treatment.
Recent Releases
Aug 4, 2010
ZIOPHARM Oncology to Present at the Canaccord Genuity 30th Annual Global Growth Conference
Jul 30, 2010
ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs
more »
Events
Sep 27, 2010
The Fifth Annual JMP Securities Healthcare Conference
Aug 11, 2010
Canaccord 30th Annual Growth Conference
more »
| 
